Moreover, although tumors of epithelial origin are predominantly Endo180-negative, expression of Endo180 in 3–6% of invasive breast cancers correlated with a basal phenotype and shorter disease-free survival [37]. The gene discussed is MRC2; the disease is invasive breast carcinoma.